TCM Biotech International (ROCO:4169) Total Stockholders Equity : NT$1,055.0 Mil (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is TCM Biotech International Total Stockholders Equity?

TCM Biotech International's Total Stockholders Equity for the quarter that ended in Dec. 2023 was NT$1,055.0 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. TCM Biotech International's Book Value per Share for the quarter that ended in Dec. 2023 was NT$17.87. The ratio of a company's debt over equity can be used to measure how leveraged this company is. TCM Biotech International's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.12.

TCM Biotech International Total Stockholders Equity Historical Data

The historical data trend for TCM Biotech International's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TCM Biotech International Total Stockholders Equity Chart

TCM Biotech International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

510.71

517.24

518.22

536.67

1,055.04

TCM Biotech International Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															518.22	531.39	536.67	543.60	1,055.04

TCM Biotech International (ROCO:4169) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

TCM Biotech International's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1055.042	-	0)	/	59.0486
	=	17.87

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

TCM Biotech International's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(58.972	+	64.502)	/	1055.042
	=	0.12

TCM Biotech International Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of TCM Biotech International's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

TCM Biotech International (ROCO:4169) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TCM Biotech International Corp (ROCO:4169) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 97, Sec. 1, Xintai 5th Road, Xizhi District, Neihu District, Taipei, TWN, 221

Website

http://www.tcmbio.com

TCM Biotech International Corp is a Taiwan based biotechnology company. It is engaged in the research and development of therapeutics for the prevention and treatment of liver diseases. Its products includes Anti-adhesion System, Anti-neoplastic agents, Osteoporosis Treatment Preparation, Iron Preparations, Osteoarthritis (OA) Treatment Products, Urinary System Treatment Products and others. The company has a business presence in Taiwan and other international countries such as the United States, Japan, Singapore, Malaysia, Vietnam, the Philippines and China. The entity derives key revenue from the sales of multiple medical products which includes medicine, medical device, functional food and others.

TCM Biotech International (ROCO:4169) Headlines

No Headlines